TENAX THERAPEUTICS, INC.·4

Apr 5, 8:08 PM ET

Jebsen Michael B 4

4 · TENAX THERAPEUTICS, INC. · Filed Apr 5, 2018

Insider Transaction Report

Form 4
Period: 2018-04-05
Jebsen Michael B
Chief Financial Officer
Transactions
  • Disposition to Issuer

    common stock

    2018-03-30$5.42/sh+6,425$34,82412,310 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT